REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/08/2025
Voltar para busca
Dado oficial do USPTO
HCCBLOODTEST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HCCBLOODTEST
ST13
US500000088311970Classe
1, 5, 9
Pedido
88311970
Registro
6126563
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
12/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
22/02/2019
Data de registro
11/08/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/08/2020
Última transação
12/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Supplemental Register
Fundamento do pedido
Foreign priority
Primeiro uso
2018-08-00
Primeiro uso no comércio
2019-02-00
Código do desenho
4
Tipo de titular
99
Localização do titular
Berlin, DE
Examinador
CORDOVA, RAUL
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Epigenomics AG
Representantes
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and sciencereagents used in sciencefor forensic examinations and test kits used in sciencein particular for verifyingdiagnosingmonitoring and predicting the progresstreatment outcome and post treatment of illnessessuch as inflammatoryinfectiouscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancer
Classe 5
Pharmaceutical productsreagents for medical usefor verifyingdiagnosingmonitoring and predicting the progresstreatment outcome and post-treatment of inflammatoryinfectiouscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancerin particular comprising of reagentschemical preparations for the diagnosis of inflammatoryinfectiouscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancerassaysdiagnostic test slidesdiagnostic test patchessold as a unit
Classe 9
Scientific instrumentsanalyzers for biological substances and samples; laboratory apparatusin particular apparatus for screening biological samplesfor detecting the presence of substances in samples and for identifying sample types; all for research use or scientific use
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/12/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
11/08/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/07/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/07/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
30/06/2020
IUAA
USE AMENDMENT ACCEPTED
30/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/06/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/06/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/06/2020
GNFR
FINAL REFUSAL E-MAILED
23/06/2020
CNFR
FINAL REFUSAL WRITTEN
23/06/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
30/05/2020
IUAF
USE AMENDMENT FILED
30/05/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
29/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/05/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/05/2020
GNSL
LETTER OF SUSPENSION E-MAILED
05/05/2020
CNSL
SUSPENSION LETTER WRITTEN
05/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/03/2020
GNRT
NON-FINAL ACTION E-MAILED
27/03/2020
CNRT
NON-FINAL ACTION WRITTEN
27/03/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/02/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
27/02/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/01/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/01/2020
CNSI
SUSPENSION INQUIRY WRITTEN
03/01/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
19/12/2019
ALIE
ASSIGNED TO LIE
13/12/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/06/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/06/2019
CNSL
SUSPENSION LETTER WRITTEN
06/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/05/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
14/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2019
GNRT
NON-FINAL ACTION E-MAILED
10/05/2019
CNRT
NON-FINAL ACTION WRITTEN
10/05/2019
DOCK
ASSIGNED TO EXAMINER
03/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/03/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/03/2019
ALIE
ASSIGNED TO LIE
28/02/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
26/02/2019
NWAP
NEW APPLICATION ENTERED
26/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HCCBLOODTEST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.